Activation of the Keap1-Nrf2/HO-1 pathway has been shown to mitigate ferroptosis in LPS-induced acute lung injury, ameliorating alveolar inflammation and oxidative stress (Li et al., 2021), thereby providing novel therapeutic insights for BPD management. Here, NFE2L2 is linked to bronchopulmonary dysplasia.